100 related articles for article (PubMed ID: 1467486)
1. [The production and characteristics of an interleukin-6-dependent hybridoma].
Kliushnenkova EN; Malaĭtseva VV
Biull Eksp Biol Med; 1992 Jul; 114(8):179-81. PubMed ID: 1467486
[TBL] [Abstract][Full Text] [Related]
2. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
[TBL] [Abstract][Full Text] [Related]
3. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
[TBL] [Abstract][Full Text] [Related]
4. Induction of hybridoma growth factor (HGF), identical to IL-6, in human fibroblasts by IL-1: use of HGF activity in specific and sensitive biological assays for IL-1 and IL-6.
Van Damme J; Van Snick J
Dev Biol Stand; 1988; 69():31-8. PubMed ID: 3265677
[TBL] [Abstract][Full Text] [Related]
5. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
McKenna SD; Chen F; Lai L; Goldschneider I
J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of recombinant chicken interleukin-6 in chicken hybridoma cells.
Nishimichi N; Aosasa M; Kawashima T; Horiuchi H; Furusawa S; Matsuda H
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):97-105. PubMed ID: 15910996
[TBL] [Abstract][Full Text] [Related]
7. Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas.
Bazin R; Lemieux R
J Immunol; 1987 Aug; 139(3):780-7. PubMed ID: 3496390
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
9. Progenitor cells in murine bone marrow stimulated by growth factors produced by the AF1-19T rat cell line.
Kriegler AB; Bradley TR; Bertoncello I; Hamilton JA; Hart PH; Piccoli DS; Hodgson GS
Exp Hematol; 1990 Jun; 18(5):372-8. PubMed ID: 2186922
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-dependent and B-cell-dependent proliferative T-cell populations in the peritoneal exudate cells of immunized mice.
Nitta T; Wakairo Y; Hirayama N; Nakano M
Kitasato Arch Exp Med; 1991 Apr; 64(1):1-14. PubMed ID: 1798235
[TBL] [Abstract][Full Text] [Related]
11. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
[TBL] [Abstract][Full Text] [Related]
12. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
13. Decline in growth and antibody production of established hybridomas and transfectomas with addition of interleukin 6.
Karavodin LM; Glasebrook AL; Phelps JL
Eur J Immunol; 1989 Jul; 19(7):1351-4. PubMed ID: 2788095
[TBL] [Abstract][Full Text] [Related]
14. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
15. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
[TBL] [Abstract][Full Text] [Related]
16. Properties of hybridomas generated by spleen cells of IL-4- and IL-13-knockout mice.
Shichkin VP; Spivak NY
Hybridoma (Larchmt); 2005 Dec; 24(6):291-7. PubMed ID: 16332195
[TBL] [Abstract][Full Text] [Related]
17. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
Zlotnik A; Fischer M; Roehm N; Zipori D
J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
[TBL] [Abstract][Full Text] [Related]
18. A raf/myc virus immortalized macrophage cell line which supports the growth of B-cell and B-cell hybridomas.
Mischak H; Kolch W; Hofer F; Weissinger E; Gessl A; Davidson WF; Aiello FB; Blaas D; Rapp UR
Oncogene; 1990 Sep; 5(9):1377-82. PubMed ID: 2216460
[TBL] [Abstract][Full Text] [Related]
19. 'Autoreactivity' of some hybridomas may be caused by a three-cell interaction.
Aihara Y; Klein J
Immunology; 1988 Mar; 63(3):389-95. PubMed ID: 3258277
[TBL] [Abstract][Full Text] [Related]
20. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
Gorczynski RM; Cohen Z; Leung Y; Chen Z
J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
